Home » Topics » BioWorld Science

BioWorld Science
RSS

ApolloBio obtains license to Toca 511/Toca FC for greater China region

April 20, 2018

Phase II E4 Relief study of Donesta achieves primary objective

April 20, 2018

FDA grants fast track designation for balixafortide plus eribulin for metastatic breast cancer

April 20, 2018

Argos Therapeutics discontinues ADAPT study based on interim analysis results

April 20, 2018

FDA grants orphan drug designation for Oraxol for the treatment of angiosarcoma

April 20, 2018

Pfizer's novel ADC CD123-CPI has broad potential for treating acute myeloid leukemia

April 20, 2018

Shire and Takeda in discussions after Shire rejects three Takeda proposals for company

April 20, 2018

KB-103 receives orphan medicinal product designation in Europe

April 20, 2018

FDA clears IND application for phase I/II study of OBI-3424

April 20, 2018

Merck KGaA presents potent and selective ATM kinase inhibitor M-3541

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...